A 75-year-old diabetic man with a cardiac history of pacemaker implantation and mechanical prosthetic valve (PV) replacement, also known for chronic osteitis of the first left metatarsophalangeal joint (MTP I), was treated with oral antibiotic on an outpatient basis with poor compliance when he developed intermittent fever (39.8 °C) and left foot pain. Laboratory testing revealed a slight elevation of the white blood cell count (10.7 G/L) and a significant elevation of the C-reactive protein (235 mg/L). Hemocultures turned positive for multi-sensitive Staphylococcus aureus and Proteus mirabilis. A left foot CT showed MTP I osteoarthritis without collection. Transoesophageal echocardiography (TOE) showed no evidence of endocarditis. A double antibiotic regimen was started, but the patient developed persistent fever. Repeated TOE raised endocarditis suspicion. Because of a newly developed cough, a search for respiratory pathogens was performed and turned positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. An 18F-FDG PET/CT was requested for investigating the suspicion of PV infection with a 72-h low-carbohydrate diet preparation.

The 18F-FDG PET maximum-intensity projection image shows (a) bilateral metabolic lung lesions, the foot infection (*), and one metabolically active draining sentinel lymph node (arrowhead). (b) Free-breathing lung CT and 18F-FDG with hypermetabolic (SUVmax 7.6 g/mL) focal ground-glass opacities with partial consolidation and mild bronchial dilatation with a peripheral distribution in the subpleural and periscissural regions of the apical and posterior segments of both upper lobes and right middle lobe, as previously described on CT [1]. (c) Hypermetabolic lymphadenopathies in the right lower paratracheal, subcarinal, and bilateral hilar stations (SUVmax 6.1 g/mL). (d, e) Absence of active PV or PM case/lead infection and no sign of septic embolism. (f) 18F-FDG PET/CT showing intense FDG accumulation in MTP I compatible with an active bone infection. (g) Comparison of 18F-FDG activity in the lung ground-glass opacities vs. the mediastinal, hilar, and paratracheal lymph nodes.

This case illustrates the benefit of 18F-FDG PET/CT in differential diagnosis of fever of multiple possible origins in the setting of SARS-CoV-2 infection [2]. In accordance with previous retrospective observations [3, 4], we confirmed the characteristic pattern of SARS-CoV-2 viral infection on 18F-FDG PET/CT with intense 18F-FDG uptake of pulmonary lesions, nodal involvement, and absence of other hypermetabolic lesions [3]. To the best of our knowledge, this is the first prospective case showing the feasibility of 18F-FDG PET/CT in patients with confirmed SARS-CoV-2 infection when taking adequate protective measures [5].

figure a